Dextrose Injection, Solution
Product Images NDC 0409-7100

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0409-7100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dextrose (Dextrose 01)

Chemical structure of dextrose monohydrate, showing the glucose ring with multiple hydroxyl groups and an attached water molecule (monohydrate).*

FDA Label Image

Figure 1 (Dextrose 02)

An instructional illustration showing a hand gripping the top of a vial, with an arrow pointing downward, likely demonstrating how to open or access the vial.*

FDA Label Image

Figure 2 (Dextrose 03)

An instructional illustration showing how to use a vial adapter to withdraw liquid medication from a vial. The image depicts a vial with a stopper and an adapter being inserted or removed by pulling upward.*

FDA Label Image

Figure 3 (Dextrose 04)

An instructional line drawing showing a hand positioning or adjusting the top port of an IV solution bag. The illustrated bag includes a spout for intravenous administration. This diagram likely demonstrates a step in preparing or using an intravenous bag for drug delivery.*

FDA Label Image

Figure 4 (Dextrose 05)

An instructional line drawing showing a hand holding and manipulating the top section of an intravenous solution bag. The image focuses on the procedure for accessing or securing the port at the top of the fluid bag, commonly used for intravenous infusions.*

FDA Label Image

Figure 5 (Dextrose 06)

An instructional diagram showing the proper technique for handling an intravenous injection solution container. It depicts two hands manipulating the container, with dotted lines indicating fluid levels and connection points for intravenous administration.*

FDA Label Image

Figure 6 (Dextrose 07)

An instructional line drawing showing a person holding an intravenous solution bag labeled as Dextrose Injection, 50 mg/mL. The illustration focuses on the hands adjusting or removing a cap or seal at the top port of the IV bag. The bag features tubing at the bottom for intravenous administration.*

FDA Label Image

Figure 7 (Dextrose 08)

An instructional illustration showing a hand holding a flexible bag designed for intravenous injection. The bag has a capped port at the top and a connector at the bottom, likely illustrating preparation or administration steps for an intravenous solution such as Dextrose 50 mg/mL injection.*

FDA Label Image

Hospira Logo (Dextrose 09)

FDA Label Image

Bag Ndc 0409-7100-68 (Dextrose 10)

Label for Dextrose 5% Injection USP, 50 mL solution for intravenous use by Hospira, Inc. The label includes dosing information, storage conditions, and a warning to mix the drug before use. NDC 0409-7100-68 is shown, indicating the product contains dextrose monohydrate at 50 mg/mL concentration.*

FDA Label Image

Bag Ndc 0409-7100-69 (Dextrose 11)

Label for Dextrose 5% Injection, USP, 100 mL intravenous solution by Hospira, Inc. The label includes dosing and usage instructions, warnings about blood transfusions, and storage conditions. It specifies the product contains 5 grams of dextrose monohydrate per 100 mL with pH and osmolarity details and highlights the need to mix before use.*

FDA Label Image

Principal Display Panel (250 mL Bag Label)

Label for 5% Dextrose Injection, USP 250 mL intravenous solution by Hospira, Inc. The label includes dosage details, storage instructions, and a warning to mix the drug before use. It is a sterile, nonpyrogenic solution containing dextrose monohydrate, distributed in a single-dose container.*

FDA Label Image

Principal Display Panel (Pouch Label)

Label from Hospira, Inc. for a Dextrose injection solution, 50 mg/mL, intended for intravenous use. The label provides instructions for opening the ADD-Vantage unit and storage conditions, emphasizing moisture barrier protection, temperature range, and sterility checks. It includes the labeler address and lot number.*

FDA Label Image

Dextrose 14

Label for Five/ADD-Vantage Units by Hospira, Inc., intended for use only with ADD-Vantage system components. The label includes storage instructions, warnings about moisture barrier overwrap and leak checks, and distribution information from Hospira, Inc., Lake Forest, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.